Insider trades: There are dozens of insider trades made each week, and reported to the SEC, which are then made public. Let’s take a look at seven of the most important you should be paying attention to.
Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), bought 1,000 shares. The move came amid safety and efficiency reports from Repros about its new drug, Androxal, which is being developed for testosterone development in men.
KB Home (NYSE:KBH) was also in the middle of two insider transactions recently. Thomas S Silk, SVP of Marketing and Communications, acquired 5,000 shares of common stock, at a price of $6.04 apiece, with the value of the deal amounting to $30,200. Jeffrey T. Mezger, President and CEO at KB Home, bought 150,000 shares, and Jeff Kaminski, EVP & Chief Financial Officer, acquired 15,000 shares.
Three insiders at Occidental Petroleum bought in: VP James Lienert, VP Edward Lowe and VP Controller Pineci Roy.